Alternating ChlVPP/PAB1OE is better than PAB1OE alone as initial chemotherapy for advanced Hodgkin's disease (HD): First results of a British National Lymphoma investigation (BNLI)/Central Lymphoma Group (CLG) study

✍ Scribed by Hancock, B.W.; Cullen, M.H.; Vaughan Hudson, G.

• Book ID: 122465416
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 255 KB
• Volume: 33
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(97)86096-0